Login / Signup

An infant case of pseudohypoaldosteronism type1A caused by a novel NR3C2 variant.

Saki NodaKohei AoyamaYuto KondoJun OkamuraAtsushi SuzukiNaoya YamaguchiAya YoshidaYoshishige Miyake
Published in: Human genome variation (2021)
Pseudohypoaldosteronism type1A (PHA1A) is the renal form of pseudohypoaldosteronism with autosomal dominant inheritance. PHA1A is caused by haploinsufficiency of the mineralocorticoid receptor, which is encoded by NR3C2. We encountered an infant who was diagnosed with PHA1A due to hyponatremia, hyperkalemia, and poor weight gain in the neonatal period. She carried a novel heterozygous mutation (NM_000901.5: c.1757 + 1 G > C) in the splice donor site of IVS-2 in NR3C2.
Keyphrases
  • weight gain
  • body mass index
  • birth weight
  • photodynamic therapy
  • mitochondrial dna
  • weight loss
  • physical activity
  • dna methylation
  • binding protein
  • acute heart failure